Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.247,16
-0,77%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Precigen Inc (PGEN) Precigen Inc (PGEN) Notizie

Precigen Inc

PGEN
1,41
0,01 (0,71%)
26 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202416:20PRNUSPrecigen to Present Late-breaking Abstract for Pivotal Phase..
24/4/202415:00PRNUSActym Therapeutics Appoints Thomas Smart as CEO
28/3/202421:05PRNUSPrecigen and Recurrent Respiratory Papillomatosis Foundation..
19/3/202421:05PRNUSPrecigen Reports Full Year 2023 Financial Results and..
19/3/202412:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
12/3/202421:05PRNUSPrecigen to Participate in a Fireside Chat Hosted by Cantor..
05/3/202422:05PRNUSPrecigen to Announce Fourth Quarter and Full Year 2023..
27/2/202419:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202421:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:25EDGAR2Form 8-K - Current report
06/2/202422:05PRNUSPrecigen to Participate in the Oppenheimer 34th Annual..
18/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
16/1/202414:05PRNUSPrecigen Receives Orphan Drug Designation for PRGN-2012 for..
08/1/202414:39EDGAR2Form 8-K - Current report
08/1/202414:30PRNUSPrecigen Highlights Pipeline Updates to be Presented at the..
29/12/202323:26EDGAR2Form S-3 - Registration statement under Securities Act of..
18/12/202322:05PRNUSPrecigen to Present at the 42nd Annual J.P. Morgan..
29/11/202322:05PRNUSPrecigen to Participate in the JMP Securities Hematology and..
09/11/202323:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:07EDGAR2Form 8-K - Current report
09/11/202322:55PRNUSPrecigen Reports Third Quarter 2023 Financial Results and..
07/11/202322:05PRNUSPrecigen to Participate in the Stifel 2023 Healthcare..
19/9/202322:05PRNUSPrecigen to Participate in Upcoming Leading Investor and..
26/8/202301:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202301:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202300:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202303:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202303:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202303:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202303:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202303:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202301:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202301:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202301:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202301:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202301:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202314:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202314:15EDGAR2Form 8-K - Current report
09/8/202314:00PRNUSPrecigen Reports Second Quarter and First Half 2023..
09/8/202313:05PRNUSPrecigen Announces FDA Confirmation that the Ongoing Phase..
05/8/202301:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202301:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202301:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202301:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202301:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:05PRNUSPrecigen to Announce Second Quarter and First Half 2023..
Apertura: 1,40 Min: 1,39 Max: 1,44
Chiusura: 1,40

La tua Cronologia

NASDAQ
PGEN
Precigen
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network